MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 52 filers reported holding MARKER THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $43 | -99.9% | 163,200 | +7.7% | 0.00% | – |
| Q3 2022 | $56,000 | -36.4% | 151,500 | -43.4% | 0.00% | – |
| Q2 2022 | $88,000 | -65.8% | 267,700 | -54.2% | 0.00% | – |
| Q1 2022 | $257,000 | -74.7% | 584,272 | -45.3% | 0.00% | -100.0% |
| Q4 2021 | $1,016,000 | -39.0% | 1,069,000 | +8.5% | 0.00% | -50.0% |
| Q3 2021 | $1,665,000 | +49.2% | 985,100 | +146.3% | 0.00% | +100.0% |
| Q2 2021 | $1,116,000 | +141.6% | 399,900 | +25.6% | 0.00% | 0.0% |
| Q4 2020 | $462,000 | +35.5% | 318,360 | +40.2% | 0.00% | – |
| Q3 2020 | $341,000 | -48.5% | 227,003 | -29.0% | 0.00% | -100.0% |
| Q2 2020 | $662,000 | +48.4% | 319,617 | +36.2% | 0.00% | – |
| Q1 2020 | $446,000 | +30.0% | 234,696 | +97.1% | 0.00% | – |
| Q4 2019 | $343,000 | – | 119,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |